Screener
Halozyme Therapeutics HALO Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity | ||
| Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock - $0.001 par value; 300,000 shares authorized; 114,042 and 117,782 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 114 | 118 |
| Additional paid-in capital | — | 12,002 |
| Accumulated other comprehensive loss | (7,830) | (18,092) |
| Retained earnings | 151,259 | 54,786 |
| Total stockholders’ equity | 143,543 | 48,814 |
| Total liabilities and stockholders’ equity | $2,577,408 | $2,525,323 |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's total liabilities & equity?
- Halozyme Therapeutics (HALO) reported total liabilities & equity of $2.58B in Q2 2026.
- How has Halozyme Therapeutics's total liabilities & equity changed year-over-year?
- Halozyme Therapeutics's total liabilities & equity increased by 25.5% year-over-year, from $2.05B to $2.58B.
- What is the long-term trend for Halozyme Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's total liabilities & equity has grown at a 34.2% compound annual growth rate (CAGR), from $579.92M to $2.53B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Halozyme Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude